Ophthalmology - Eye Health Academy

1-16 of 61

Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
CME/CE
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Diana V. Do, MD; Janis T. Eells, Ph.D.
1.50 credits
- Diana V. Do, MD
- Janis T. Eells, Ph.D.
- David Boyer, MD
- Eleonora Lad, MD, PhD
- Marion R. Munk, MD, PhD
1.50 credits
Applying CAS, EUGOGO, VISA: A Micro Case
Applying CAS, EUGOGO, VISA: A Micro Case
MinuteCE®
Applying CAS, EUGOGO, VISA: A Micro Case
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
1.00 program credit
Overcoming Real-World Barriers to TED Treatment 
Overcoming Real-World Barriers to TED Treatment 
MinuteCE®
Overcoming Real-World Barriers to TED Treatment 
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
1.00 program credit
Why QoL Measures Change TED Management
Why QoL Measures Change TED Management
MinuteCE®
Why QoL Measures Change TED Management
Prem S. Subramanian, MD, PhD; Kimberly Cockerham, MD
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Kimberly Cockerham, MD
1.00 program credit
MinuteCE®
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 credit 8 episodes
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
- Kimberly Cockerham, MD
1.00 credit 8 episodes
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
MinuteCE®
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Andrea Lora Kossler, MD, FACS; Kimberly Cockerham, MD
1.00 program credit
- Andrea Lora Kossler, MD, FACS
- Kimberly Cockerham, MD
1.00 program credit
Designing Efficient Clinic Workflows for TED Therapy Access
Designing Efficient Clinic Workflows for TED Therapy Access
MinuteCE®
Designing Efficient Clinic Workflows for TED Therapy Access
Prem S. Subramanian, MD, PhD; Kimberly Cockerham, MD
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Kimberly Cockerham, MD
1.00 program credit
Why Staging TED Correctly Matters Even When CAS Is Low
Why Staging TED Correctly Matters Even When CAS Is Low
MinuteCE®
Why Staging TED Correctly Matters Even When CAS Is Low
Andrea Lora Kossler, MD, FACS; Kimberly Cockerham, MD
1.00 program credit
- Andrea Lora Kossler, MD, FACS
- Kimberly Cockerham, MD
1.00 program credit
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
MinuteCE®
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
1.00 program credit
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
MinuteCE®
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Prem S. Subramanian, MD, PhD; Kimberly Cockerham, MD
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Kimberly Cockerham, MD
1.00 program credit
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
CME/CE Broadcast Replay
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD; Andrew G. Lee, MD
1.00 credit
- Prem S. Subramanian, MD, PhD
- Andrew G. Lee, MD
- Valerie Biousse, MD
1.00 credit
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Deepak Sambhara, MD
0.25 credits
- Deepak Sambhara, MD
0.25 credits
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Eichenbaum, MD
0.25 credits
- David Eichenbaum, MD
0.25 credits
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Chin Yee, MD, FASRS
0.25 credits
- David Chin Yee, MD, FASRS
0.25 credits
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Esther Lee Kim, MD
0.25 credits
- Esther Lee Kim, MD
0.25 credits
Retina Case Review: Translating the Data Into Care
Retina Case Review: Translating the Data Into Care
CME/CE
Retina Case Review: Translating the Data Into Care
Durga Borkar, MD, MMCi; Veeral Sheth, MD, MBA, FASRS, FACS
0.25 credits
- Durga Borkar, MD, MMCi
- Veeral Sheth, MD, MBA, FASRS, FACS
0.25 credits

Prev
1
2
3
4
Next

1/4